Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs

Stock Information for Lucid Diagnostics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Lucid Diagnostics Inc.

Stereotaxis to Participate in Piper Sandler 37th Annual Healthcare Conference
Stereotaxis Reports 2025 Third Quarter Financial Results
GenesisX Robotic Magnetic Navigation System Receives U.S. FDA Clearance
Stereotaxis to Report Third Quarter 2025 Financial Results on November 11, 2025
Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias
Erasmus Medical Center Advances Cardiovascular Care with Genesis Robotic System
First US Commercial Robotic HD Mapping Procedures Successfully Completed with MAGiC Sweep Catheter
Stereotaxis to Present at Upcoming Investor Conferences

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.